Skip to main content
. 2021 Mar 11;11:628807. doi: 10.3389/fonc.2021.628807

Figure 6.

Figure 6

Associations between survival probability and mutations in pretreatment tumor samples. Hazards ratios (HRs) are shown separately for pretreatment samples of rrDLBCL and all DLBCL including cured disease. HR and P values were corrected by the COO and IPI score. (A, B) Genes with P values < 0.05 in the univariate analysis for rrDLCL are included. (C, D) Pathways with > 9 mutated rrDLBCL samples are included.